Illumina

In this new Science article, Nima Aghaeepour, PhD (Stanford University) and David Fajgenbaum, MD, MBA, MSc (University of Pennsylvania and Every Cure) share how they are leveraging high-plex proteomics powered by next-generation affinity reagents to uncover disease mechanisms, identify novel biomarkers, and reveal potential therapeutic targets. 👇 Read more below. #Proteomics #Multiomics #BiomarkerDiscovery #DrugDiscovery #Biomarkers #DrugDevelopment #Research

How should sequencing performance be evaluated: by isolated screenshots or by comprehensive benchmarks? We took a closer look at recent questions about TruPath Genome and compared the examples with established truth sets. Our analysis shows why individual loci can be useful starting points, but cannot support technology-level conclusions on their own. Rigorous, variant-appropriate benchmarking is the standard. See the data and methods in our analysis. Read the analysis: https://lnkd.in/eymHAPWW

Being a good corporate citizen isn't a single achievement -- it's a practice. For the 5th year in a row, Illumina has been named to 3BL's 100 Best Corporate Citizens list, moving up to #24 overall and ranking #1 in our industry. This recognition reflects the work of our employees worldwide who show up every day for our customers, community, and planet. https://bit.ly/47o9ehB #100BestCC #Sustainability #CorporateResponsibility

Twenty-five years ago, the announcement of the first draft of the human genome gave the world an unprecedented blueprint for understanding human biology. Today, genomics is entering a new chapter, one focused on turning scientific discovery into meaningful impact for human health. During a recent visit to China, Illumina Chief Medical Officer Eric Green, M.D., Ph.D. met with research and industry leaders to reflect on how far genomics has come and explore what lies ahead, from deeper biological insights to more precise approaches to health. Read more about the next chapter of genomics: Beyond the Human Genome Project: What’s next for genomics? https://bit.ly/3TRCFFH #Genomics #PrecisionHealth #HumanGenomeProject #Innovation

What becomes possible when curious minds meet?   Follow Illumina CMO, Dr. Eric Green through a high-energy visit in Beijing, from exploring the Illumina Bioinformatics Mobile Workstation to exchanging ideas with biopharma leaders and young scientists. Along the way, he reflects on how genomics is advancing therapeutics, encourages young researchers to embrace new possibilities, and reminds us that the most exciting part of the genomics journey may still lie ahead. Watch the vlog for highlights from a day filled with curiosity, conversations and inspiration. #Genomics #ScientificExchange #LifeSciences #FutureOfHealth

One platform. More sample types. Deeper discovery. Advance what's possible with Illumina SomaSeq™ Discovery new pre-plated Serum, Plasma, and Multi Matrix Kits — expanding proteomic analysis to tissue homogenates, and cell lysates to deliver sensitive, comprehensive protein detection that powers biomarker discovery and informs disease mechanism research. Highlights: ✅ Broad proteomic coverage with 11K proteins measured across 200+ biological pathways ✅ High-sensitivity detection with femtomolar sensitivity and >10-log dynamic range, across expanded sample types ✅ Reproducible insights that move research programs forward ✅ Advanced normalization tool lets your biology set the reference across studies Learn how expanded sample types can strengthen biological interpretation and accelerate translational research. https://bit.ly/47g1puc #Proteomics #DrugDiscovery #PrecisionMedicine #Multiomics

Heading to #HUPO2026? Join us at Illumina Booth #128! Visit us at HUPO 2026 to discover how Illumina SomaSeq™ Discovery and Illumina SomaScan™ Discovery* are enabling large-scale proteomics research with broad proteome coverage, high-quality reproducible data, and applications spanning biomarker discovery to population-scale studies. 📍 Illumina Booth #128 🎤 Industry-Supported Seminar Series 📅 September 29 & 30, 2026 Join leading experts as they share the latest advances in proteomics and multiomics research, along with real-world applications driving new discoveries in disease research. Learn more: https://bit.ly/4iCjz0s #Proteomics #ScientificResearch #BiomarkerDiscovery #LifeSciences *For Research Use Only. Not for use in diagnostic purposes.

Our innovation roadmap continues to unlock breakthrough insights that will shape the future of oncology research.     At #ECP2026 we’ll hear from researchers and innovators who are putting Illumina’s latest innovations to the test across sequencing, bioinformatics, and workflow design to support oncology researchers and healthcare systems researchers as they navigate an increasingly complex genomic landscape.    Watch the on-demand Illumina Innovation Roadmap to learn more about the future of genomic innovation in oncology research: https://lnkd.in/g4tQ2sKU #ESPCongress

Illumina adopted a middle school. What happened next changed the narrative. Over the course of a year, students at Akira R. Toki Middle School extracted DNA from strawberries, stepped inside a genomics company, explored unexpected career paths, and began imagining new possibilities for their futures. But the real impact came from something simpler: showing up again and again. Through hands-on STEM experiences, career conversations, transportation support, community events, and even a transformed school library, Illumina employees worked alongside educators to support the needs of the entire school community. As Principal Sheba Mays put it: “Toki is seen and valued.” See how a year-round partnership helped turn curiosity into possibility 👉 https://bit.ly/3SRDv4V